Literature DB >> 21225186

Castleman's disease associated with follicular dendritic cell sarcoma and myasthenia gravis.

Fernando Luiz Westphal1, Luís Carlos de Lima, Luiz Carlos Lopes Santana, José Corrêa Lima Netto, Vanise Campos Gomes Amaral, Márcia dos Santos da Silva.   

Abstract

Castleman's disease is an atypical lymphoproliferative disorder of unknown etiology, which might be associated with various clinical conditions, including autoimmune diseases and malignant neoplasms. We report the case of a 72-year-old female patient who was referred to the thoracic surgery department of Getúlio Vargas University Hospital, in the city of Manaus, Brazil, for the resection of a posterior mediastinal tumor. Three months prior, the patient had been admitted to the ICU with signs of severe dyspnea, at which time she was diagnosed with myasthenia gravis. After the resection of the mediastinal tumor, the histopathological examination revealed hyaline vascular-type Castleman's disease, complicated by follicular dendritic cell sarcoma. At this writing, the patient was being treated with an anticholinesterase agent and corticosteroids for the control of myasthenia gravis.

Entities:  

Mesh:

Year:  2010        PMID: 21225186     DOI: 10.1590/s1806-37132010000600020

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  4 in total

Review 1.  Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature.

Authors:  Zheng Su; Gaojie Liu; Jianping Liu; Tingfeng Fang; Yunjie Zeng; Huayao Zhang; Shanglin Yang; Yang Wang; Junmin Zhang; Jinxing Wei; Yingru Li; Youfeng Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  A Case Report of Subclinical Myasthenia Gravis Associated with Castleman's Disease.

Authors:  Tuqa Adil Alsinan; Hassan Ahmad Robaidi; Waleed Neamatallah Saleh
Journal:  Am J Case Rep       Date:  2021-06-11

3.  Radiation therapy in the treatment of unicentric Castleman's disease.

Authors:  Fabiana Accioli Miranda; Victor Hugo Chiquetto Faria; Gustavo Viani Arruda; Lucas Godoi Bernardes da Silva
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

4.  Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.

Authors:  Tatsuya Aoki; Mikio Wada; Atsushi Kawashima; Kouichi Hirakawa; Akihiro Nagata; Keizo Kagawa
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.